Phillips, D. C., Jin, S., Gregory, G. P., Zhang, Q., Xue, J., Zhao, X., . . . Souers, A. J. (2019). A novel CDK9 inhibitor increases the efficacy of venetoclax (ABT-199) in multiple models of hematologic malignancies. Leukemia.
Citação norma ChicagoPhillips, Darren C., et al. "A Novel CDK9 Inhibitor Increases the Efficacy of Venetoclax (ABT-199) in Multiple Models of Hematologic Malignancies." Leukemia 2019.
Citação norma MLAPhillips, Darren C., et al. "A Novel CDK9 Inhibitor Increases the Efficacy of Venetoclax (ABT-199) in Multiple Models of Hematologic Malignancies." Leukemia 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.